GlaxoSmithKline PLC News Headlines

GSK 
$52.51
*  
0.31
 negative 
0.59%
Get GSK Alerts
*Delayed - data as of Apr. 17, 2014 
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

10 Of 17 Top Sin Stocks Stalk 7% To 22% Upsides
4/18/2014 10:38:00 AM - Seeking Alpha

Glaxo Looking into Misconduct Charges - Analyst Blog
4/17/2014 6:35:01 PM - Zacks.com

GSK, Genmab Get FDA Approval For Arzerra As First-Line Treatment For CLL
4/17/2014 4:09:00 PM - RTT News

Cohen’s Point72 Asset Management buys a stake in Cytokinetics
4/17/2014 3:45:00 PM - Market Realist

Pharmaceutical Stocks For Income, Value And Growth Investors
4/17/2014 12:46:16 PM - Benzinga

Galapagos: GSK2586184 Meets Primary Endpoint In Phase2a Psoriasis Study
4/17/2014 4:01:00 AM - RTT News

Glaxo's Tanzeum Approved in the U.S. - Analyst Blog
4/16/2014 6:33:01 PM - Zacks.com

Dynavax Starts Phase III Study on Heplisav-B - Analyst Blog
4/16/2014 4:10:01 PM - Zacks.com

Mylan Inks Two Separate Agreements - Analyst Blog
4/16/2014 11:10:01 AM - Zacks.com

European Stocks Set To Follow Asian Markets Higher
4/16/2014 2:27:00 AM - RTT News

DVAX Moves On, GSK Gets FDA Nod, HART-Warming, ZGNX Gains On Favorable Ruling
4/16/2014 12:15:00 AM - RTT News

FDA Approves GSK's Once-weekly Type 2 Diabetes Treatment Tanzeum
4/15/2014 6:25:00 PM - RTT News

Glaxo Wins U.S. Approval for Diabetes Drug
4/15/2014 2:25:00 PM - Dow Jones Business News

Glaxo Wins U.S. Approval for Diabetes Treatment Albiglutide
4/15/2014 2:13:00 PM - Dow Jones Business News

GlaxoSmithKline Gets FDA Approval for Diabetes Drug
4/15/2014 1:18:00 PM - Dow Jones Business News

LONDON MARKETS: FTSE 100 Turns Higher As Mining Stocks Strengthen
4/14/2014 1:05:00 PM - Dow Jones Business News

EUROPE MARKETS: European Stocks Swing To Gains Following Sell Off
4/14/2014 12:44:00 PM - Dow Jones Business News

BBC: GSK Faces Bribery Probe In Poland
4/13/2014 9:48:00 PM - RTT News

AmpliPhi Biosciences: A Speculative Play In Biopharmaceuticals Too Compelling To Ignore
4/11/2014 9:49:00 AM - Seeking Alpha

Critical Shortage Of Injectables Create Opportunity For Drugmakers
4/9/2014 4:46:00 PM - Seeking Alpha

Teva to Launch Generic Lovaza - Analyst Blog
4/9/2014 4:45:01 PM - Zacks.com

Pharmacyclics Files sNDA - Analyst Blog
4/9/2014 11:30:01 AM - Zacks.com

Daily Stock Chart Analysis: GlaxoSmithKline Stock (NYSE: GSK)
4/9/2014 4:15:10 AM - Wyatt Investment Research

How One Retiree Is Muddling Through Dividend Investing: Part IX - My Dividend Investment Business Plan
4/9/2014 3:56:00 AM - Seeking Alpha

Glaxo and Amgen Terminate Agreement - Analyst Blog
4/4/2014 4:45:01 PM - Zacks.com